Wise develops gamified OTC and prescription digital therapeutics that are engaging, accessible, and clinically effective.
Leveraging a proprietary engine based on the principles of a cognitive therapy technique called attention bias modification treatment (ABMT), Wise’s digital therapeutics have demonstrated through numerous randomized placebo-controlled clinical trials (RCTs) to have a meaningful impact on biometric and behavioral endpoints associated with stress and anxiety.